Melonie Warfel
VP & GM of Life Sciences
Lonergan Partners is pleased to announce that Melonie Warfel has been named Vice President & General Manager at Model N. The search was led by Michael Cunningham.
About Melonie
Melonie joined Model N as VP and GM of Life Sciences in February 2019. She is responsible for growing the life sciences vertical and developing the next-generation strategy and go-to-market processes to support continued expansion across the business.
Prior to joining Model N, Melonie spent 3 years at Veeva Systems working on Veeva Vault across Pharma and Medical Device & Diagnostics. Prior to that she spent 6 years at Pegasystems building and growing their life sciences practice and 18 years at Adobe Systems, where she drove the development of the company’s vertical business strategy across life sciences, healthcare, manufacturing and government, as well as global PDF-based standards.
Melonie completed executive education programs in strategic planning and implementation at the Ross School of Business as well as finance at the Wharton School of Business.
About Model N
Model N, Inc. is the leader in revenue management solutions. Driving mission-critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high-tech manufacturing, and semiconductor across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor.
I am excited that Melonie is joining our team to provide leadership in our life sciences business. She has a tremendous amount of domain expertise combined with a broad background in enterprise software. Her expertise will be help accelerate Model N’s momentum and leadership in revenue management.
Jason Blessing, CEO, Model N
I am delighted to join Model N, the market leading Revenue Management solutions company supporting the Life Sciences industry. I look forward to making a positive impact by growing and expanding our SaaS based offerings into existing and new customers across pharmaceutical, healthcare and medical device and diagnostics organizations. Model N is unique in that the organization has deep industry expertise and is well positioned for significant market expansion through focus, execution and customer success. I'm very excited to be part of the Model N team.
Melonie Warfel, SVP & GM Life Sciences, Model N
Melonie is a dynamic go-to-market leader who has a unique understanding of next-gen cloud software solutions utilized by the life sciences industry. Her strategic insights and extensive customer interface experience will enable Model N to grow its top-line in this sector.
Michael Cunningham, Partner, Lonergan Partners